Search - tctmd.com

Displaying 1 - 20 of 1957

Sort: Relevancy | Date

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

News Conference News ACC 2026

Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering

Michael O'Riordan

April 01, 2026

Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI

News Conference News ACC 2026

Novel Cerebral Protection Device Matches Up Well With Sentinel in TAVI

March 30, 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

News Conference News ACC 2026

Impella Support in High-Risk PCI Doesn’t Help, Might Harm: CHIP-BCIS3

Yael L. Maxwell

March 29, 2026

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

News Daily News

US Societies Lay Out Requirements for Transcatheter Tricuspid Valve Procedures

Michael O'Riordan

March 27, 2026

What’s Going to Be Hot at ACC 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Yael L. Maxwell

March 16, 2026

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

News Conference News CRT 2026

DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients

March 09, 2026

Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data

News Conference News THT 2026

Baroreflex Activation for Advanced HF Yields Positive Results: Postmarketing Data

March 05, 2026

HBR Common, Impactful Among All-Comer Acute MI Patients

News Daily News

HBR Common, Impactful Among All-Comer Acute MI Patients

Yael L. Maxwell

March 05, 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

News Conference News THT 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

March 04, 2026

AI in Cardiovascular Imaging and Interventions: Boon or Bane?

News Conference News EAPCI 2026

AI in Cardiovascular Imaging and Interventions: Boon or Bane?

February 20, 2026

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

News Daily News

Higher Reintervention Risk With TAVI Emerges at 6 to 7 Years in Evolut Low Risk Trial

Michael O'Riordan

February 19, 2026

February 2026 Dispatch for the CV Team

News Opinion CV Team Dispatch

February 2026 Dispatch for the CV Team

February 18, 2026

Q&A Lior Jankelson on AI Tools for Suspected ACS and More

News Daily News

Q&A: Lior Jankelson on AI Tools for Suspected ACS and More

February 10, 2026

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

News Conference News ISC 2026

CHOICE-2 Bolsters Intra-arterial Lytics After Stroke Thrombectomy

February 06, 2026

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

News Daily News

FAME 2 at 10 Years: Less Urgent Revascularization With FFR-Guided PCI

Michael O'Riordan

January 26, 2026

HF Care Differs Among Asian Subgroups in the US

News Daily News

HF Care Differs Among Asian Subgroups in the US

January 16, 2026

Delays in STEMI Cardiogenic Shock Care Come at a Cost: DanGer Shock

News Daily News

Delays in STEMI Cardiogenic Shock Care Come at a Cost: DanGer Shock

January 15, 2026

Revathy Sampath-Kumar, MD

News Featured Fellow

Revathy Sampath-Kumar, MD

Yael L. Maxwell

January 13, 2026

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

News Daily News

Weight Regained Within 18 Months of Stopping GLP-1 Drugs

Michael O'Riordan

January 08, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.